Update on treatment of light chain amyloidosis by

Update on treatment of light chain amyloidosis by Shameem Mahmood, Giovanni Palladini, Vaishali Sanchorawala, and Ashutosh Wechalekar haematol Volume 99(2): 209 -221 February 4, 2014 © 2014 by Ferrata Storti Foundation

Common types of systemic amyloidosis. Shameem Mahmood et al. Haematologica 2014; 99: 209 -221

Pathogenesis and presentation of AL amyloidosis. Shameem Mahmood et al. Haematologica 2014; 99: 209

Diagnostic and Staging Investigations for systemic AL amyloidosis. Shameem Mahmood et al. Haematologica 2014;

Consensus hematologic response in systemic light chain (AL) amyloidosis. 22. Shameem Mahmood et al.

Confirming the diagnosis and fibril typing in a patient with AL amyloidosis due to underlying kappa light chain secreting plasma cell dyscrasia. Shameem Mahmood et al. Haematologica 2014; 99: 209 -221 © 2014 by Ferrata Storti Foundation

Radionuclide imaging in amyloidosis: 123 I labeled serum amyloid P component scintigraphy showing uptake in the spleen and liver in a patient with AL amyloidosis (left). Shameem Mahmood et al. Haematologica 2014; 99: 209 -221 © 2014 by Ferrata Storti Foundation

Overall survival in AL amyloidosis stratified by hematologic response in patients treated with high-dose melphalan and autologous stem cell transplantation in a landmark analysis of 140 patients showing superior OS in those achieving a CR and v. GPR (median O. . . Shameem Mahmood et al. Haematologica 2014; 99: 209 -221 © 2014 by Ferrata Storti Foundation